NCSTN and histiocytic sarcoma: Perhaps the clearest insights into HS pathogenesis are the estimated 1–5% of patients with autosomal dominant mutations, usually in subunits of the gamma secretase (GS) protein complex, with the majority of those in Nicastrin (NCSTN)14,33–35.